Received Jun 30, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 3 | UNK | RA |
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | UNK | RA |
Extra dose administered; Inappropriate schedule of vaccine administered; This non-serious case was reported by a consumer via call center representative and described the occurrence of extra dose administered in a 71-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis. Co-suspect products included Herpes zoster (Shingrix) for prophylaxis. Concomitant products included Varicella zoster vaccine rgE (CHO) (Shingrix) and methotrexate sodium (Methotrexate). On 30-AUG-2018, the patient received the 3rd dose of Shingrix (right arm). On 19-JUL-2018, the patient received the 2nd dose of Shingrix (right arm). On 19-JUL-2018, not applicable after receiving Shingrix and an unknown time after receiving Shingrix, the patient experienced drug dose administration interval too short (Verbatim: Inappropriate schedule of vaccine administered). On 30-AUG-2018, the patient experienced extra dose administered (Verbatim: Extra dose administered). The outcome of the extra dose administered and drug dose administration interval too short were not applicable. Additional Information: GSK receipt date: 20-JUN-2025 The patient did not have any Lot number of expiry information for any of the three doses received The reporter was a male patient that reported that he was looking at his vaccination records, and it showed that he received three doses of Shingrix. The patient received a third dose of Shingrix on 30th August 2018 which led to extra dose administration. The patient received the first dose of Shingrix on 30th May 20218, and the second dose on 19th July 2018, not two months apart which led to drug dose administration interval too short. The patient stated that there was a good chance that he received all three doses in his right arm, but he did not have this information in his records. The patient stated that neither his local pharmacy nor his physician showed any record of having provided any Shingrix vaccines to him. The patient had no Healthcare Provider information available to provide The patient mentioned that he was on Methotrexate (unknown product information) pre-existing receiving any Shingrix vaccines and is still on Methotrexate today at the time of reporting.
Shingrix; Methotrexate